Stay updated on Nivolumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the Nivolumab Combo in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedRemoved the disease label 'Multiple myeloma' and the related topics section including the MedlinePlus Genetics link. The change alters how the page presents its disease focus and related resources.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision tag updated to v3.6.6, replacing the previous v3.6.5. This reflects a version update for the page, not a modification to the study details or visible content.SummaryDifference0.0%

- Check16 days agoChange DetectedAn NIH grant/contract reference was added in the study's identifiers, indicating funding background for the trial.SummaryDifference0.0%

- Check23 days agoChange DetectedThe related topics section now lists Multiple myeloma and MedlinePlus Genetics, indicating the study's disease focus and offering a genetics resource for readers.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5. This indicates a new build of the study details page and accompanying updates.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page's revision badge was updated from v3.6.3 to v3.6.4. Related topics such as Multiple myeloma and MedlinePlus Genetics were removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Multiple Myeloma Clinical Trial page.